Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: archive
2005
PHARMAC documents that matched your search:
Proposed listing of...
(1 page, 59 KB)
2005/12/23
...hydrogen peroxide (Crystacide), capsaicin cream (Zostrix HP), sodium alginate (Acidex) and procarbazine hydrochloride (Natulan) in the Pharmaceutical Schedule.
Invitation to Tender – supply of pharmaceuticals to DHB hospitals and/or to community pharmacies
(101 pages, 573 KB)
2005/12/22
PHARMAC, AstraZeneca finalise agreement on goserelin
(1 page, 52 KB)
2005/12/22
PHARMAC and AstraZeneca have finalised an agreement for the prostate and breast cancer drug goserelin (Zoladex)...
Goserelin to remain available to NZers
(1 page, 50 KB)
2005/12/19
People with prostate cancer and breast cancer will continue to have fully funded access to the hormonal treatment goserelin (Zoladex) following an agreement between Government drug-funding agency PHARMAC and pharmaceutical company AstraZeneca...
PHARMAC disappointed at drug company decision
(1 page, 59 KB)
2005/12/14
PHARMAC is disappointed at the knee-jerk reaction of a drug multinational that will deprive New Zealanders of a medicine to treat prostate cancer and breast cancer, Chief Executive Wayne McNee says...
